VTL - Vital Therapies, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 512.84M
Enterprise Value 3-4.59M
Trailing P/E N/A
Forward P/E 1-10.10
PEG Ratio (5 yr expected) 1-0.02
Price/Sales (ttm)N/A
Price/Book (mrq)0.90
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 60.09

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-69.34%
Return on Equity (ttm)-140.44%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -49.27M
Net Income Avi to Common (ttm)-53.6M
Diluted EPS (ttm)-1.266
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.8M
Total Cash Per Share (mrq)0.42
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.35
Book Value Per Share (mrq)0.34

Cash Flow Statement

Operating Cash Flow (ttm)-48.43M
Levered Free Cash Flow (ttm)-28.12M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.49
52-Week Change 3-94.25%
S&P500 52-Week Change 31.52%
52 Week High 39.750
52 Week Low 30.230
50-Day Moving Average 30.322
200-Day Moving Average 34.621

Share Statistics

Avg Vol (3 month) 36.17M
Avg Vol (10 day) 31.25M
Shares Outstanding 542.37M
Float 39.12M
% Held by Insiders 11.32%
% Held by Institutions 120.62%
Shares Short (Oct 31, 2018) 44.49M
Short Ratio (Oct 31, 2018) 40.68
Short % of Float (Oct 31, 2018) 414.90%
Short % of Shares Outstanding (Oct 31, 2018) 410.59%
Shares Short (prior month Sep 28, 2018) 43.28M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A